Advertisement

Laserbehandlung des lokalisierten Prostatakarzinoms

  • H. O. Beisland

Zusammenfassung

Lokalisiertes Prostatakarzinom ist definitionsgemäß Tumorwachstum innerhalb der Drüse ohne Lymphknotenmitbeteiligung oder Fernmetastasen. Mit geeigneten Behandlungsmaßnahmen müßte es theoretisch möglich sein, diese Patienten zu heilen, und dafür ist die Anwendung von radikaler Prostatektomie, externer Strah-lenbehandlung und radioaktiven Implantaten seit Jahren praktiziert worden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bagshaw MA (1984) Radiotherapy of prostatic cancer. Stanford University experience. Prog Clin Biol Res 153: 493–512PubMedGoogle Scholar
  2. 2.
    Beisland HO, Sanders S (1986) First clinical experiences on Neodymium-YAG laser irradiation of localized prostatic cancer. Scand J Urol Nephrol 20: 113–117PubMedCrossRefGoogle Scholar
  3. 3.
    Beisland HO, Stranden E (1984) Rectal temperature monitoring during Neodymium-YAG laser irradiation for prostatic carcinoma. Urol Res 12: 257–259PubMedCrossRefGoogle Scholar
  4. 4.
    Bowering R, Hofstetter A, Keiditsch E, Frank F (1979) Irradiation of prostatic carcinoma by Neodymium-YAG laser. Optics and Photonics Applied to Medicine 211: 16–20Google Scholar
  5. 5.
    Fowler JE, Whitmore WF (1981) The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer 47: 2941–2945PubMedCrossRefGoogle Scholar
  6. 6.
    Grossmann HB, Batata M, Hilaris B, Whitmore WF (1982) 125I implantation for carcinoma of prostate. Further follow-up of first 100 cases. Urology 20: 591–598CrossRefGoogle Scholar
  7. 7.
    Guerriero WG, Carlton CE, Hudgins PT (1980) Combined interstitiell and external radiotherapy in the definitive management of carcinoma of the prostate. Cancer 45: 1922–1928PubMedGoogle Scholar
  8. 8.
    Haldorsson T (1981) Biophysical fundamentals and instrumentation for the endovesical Nd- YAG laser application. Urologe (A) 20: 293–299Google Scholar
  9. 9.
    Kronester A, Staehler G, Weinberg W, Keiditsch E (1981) Risk of intestinal damage from endoscopic Neodymium-YAG laser irradiation of bladder tumors. Urologe (A) 20: 305–309Google Scholar
  10. 10.
    McNicholas TA, Carter S StC, Wickham JEA, O’Donoghue EPN (1988) YAG Laser treat-ment of early carcinoma of the prostate. Br J Urol 61: 239–243PubMedCrossRefGoogle Scholar
  11. 11.
    Sander S, Beisland HO (1981) Laser in the treatment of localized prostatic cancer. J Urol 132: 280–281Google Scholar
  12. 12.
    Sander S, Beisland HO, Fossberg E (1982) Neodymium-YAG laser in the treatment of prostatic cancer. Urol Res 10: 85–86PubMedCrossRefGoogle Scholar
  13. 13.
    Wilson CS, Dahl SD, Middleton RG (1977) Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer. J Urol 117: 197–198PubMedGoogle Scholar
  14. 14.
    Zincke H, Farrow GM, Myers RP, Benson RC, Furlow WL, Utz DC (1982) Relationship between grade and stage of adenocarcinoma of the prostate and regional lymph node metastases. J Urol 128: 498–501PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • H. O. Beisland
    • 1
  1. 1.Aker HospitalOslo 5, NorwegenNorway

Personalised recommendations